Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIX study: Effects of Lixelle on amyloid bone cysts in dialysis patients evaluated by high-resolution CT
jRCTs072180089Completed
- Sponsor
- Kaneka
- Start
- Jul 2018
- Countries
- 1
01
Overview
Open-label trial of Lixelle in Beta-2-microglobulin amyloidosis (DRA) (2 arms), sponsored by Kaneka. Primary endpoint: Change in cyst volume of carpal bones at 12 months. Started Jul 2018; status: completed.
02
Drugs
Lixelle
03
Conditions
Beta-2-microglobulin amyloidosis (DRA)
Beyond the preview
Go deeper on jRCTs072180089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs072180089.